ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Mapping the pharmacological modulation of brain oxygen metabolism: The effects of caffeine on absolute CMRO<sub>2</sub> measured using dual calibrated fMRI.

脳酸素代謝の薬理学的調節のマッピング:デュアル較正fMRIを用いて測定した絶対CMRO2に対するカフェインの効果 (機械翻訳の邦題)

NeuroImage2017Merola A, Germuska MA, Warnert EA, et al.
研究デザインランダム化比較試験
対象ヒト

記録の確認項目

研究デザイン
ランダム化比較試験
対象
ヒト
出版年
2017
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

本研究は、新規MRI法を用いて、カフェイン摂取が灰白質の酸素代謝と血行動態に及ぼす急性効果をマッピングすることを目的とした。無作為化二重盲検プラセボ対照試験で、16人の健康なカフェイン消費者を対象に、カフェイン250mgまたはプラセボ経口投与前後で、二重較正fMRI実験と多反転時間ASLを用いて、酸素抽出率(OEF)、脳血流(CBF)、CBF関連脳血管反応性、脳酸素消費代謝率(CMRO2)の灰白質マップを推定した。その結果、カフェインによりOEFは15.6%増加、CBFは30.4%減少、CMRO2は18.6%減少した。CMRO2減少は前頭回、頭頂葉、後頭葉で顕著であり、脳酸素代謝と血行動態への薬物効果をボクセル単位でマッピングする方法として提案された。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

This study aims to map the acute effects of caffeine ingestion on grey matter oxygen metabolism and haemodynamics with a novel MRI method. Sixteen healthy caffeine consumers (8 males, age=24.7±5.1) were recruited to this randomised, double-blind, placebo-controlled study. Each participant was scanned on two days before and after the delivery of an oral caffeine (250mg) or placebo capsule. Our measurements were obtained with a newly proposed estimation approach applied to data from a dual calibration fMRI experiment that uses hypercapnia and hyperoxia to modulate brain blood flow and oxygenation. Estimates were based on a forward model that describes analytically the contributions of cerebral blood flow (CBF) and of the measured end-tidal partial pressures of CO2 and O2 to the acquired dual-echo GRE signal. The method allows the estimation of grey matter maps of: oxygen extraction fraction (OEF), CBF, CBF-related cerebrovascular reactivity (CVR) and cerebral metabolic rate of oxygen consumption (CMRO2). Other estimates from a multi inversion time ASL acquisition (mTI-ASL), salivary samples of the caffeine concentration and behavioural measurements are also reported. We observed significant differences between caffeine and placebo on average across grey matter, with OEF showing an increase of 15.6% (SEM±4.9%, p<0.05) with caffeine, while CBF and CMRO2 showed differences of -30.4% (SEM±1.6%, p<0.01) and -18.6% (SEM±2.9%, p<0.01) respectively with caffeine administration. The reduction in oxygen metabolism found is somehow unexpected, but consistent with a hypothesis of decreased energetic demand, supported by previous electrophysiological studies reporting reductions in spectral power with EEG. Moreover the maps of the physiological parameters estimated illustrate the spatial distribution of changes across grey matter enabling us to localise the effects of caffeine with voxel-wise resolution. CBF changes were widespread as reported by previous findings, while changes in OEF were found to be more restricted, leading to unprecedented mapping of significant CMRO2 reductions mainly in frontal gyrus, parietal and occipital lobes. In conclusion, we propose the estimation framework based on our novel forward model with a dual calibrated fMRI experiment as a viable MRI method to map the effects of drugs on brain oxygen metabolism and haemodynamics with voxel-wise resolution.

MeSH

AdultCaffeineCentral Nervous System StimulantsCerebrovascular CirculationDouble-Blind MethodFemaleFunctional NeuroimagingGray MatterHumansMagnetic Resonance ImagingMaleOxygen ConsumptionYoung Adult

DOI 10.1016/j.neuroimage.2017.03.028

PMID 28323164

原文・出典を見る →